To Evaluate the Efficacy and Safety of N-acetyl Cysteine Administration in Patients With Diabetic Retinopathy

Abroad (travel likely)RecruitingPHASE4

Conditions

Diabetic Retinopathy (DR)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institute of Diabetes and Endocrinology., Cairo, Egypt
Contact: Study coordinator (National Institute of Diabetes and Endocrinology. National Institute of Diabetes and Endocrinology.)
National Institute of Diabetes and Endocrinology., Cairo, Egypt

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Proteomic Biomarker Identification in Age-Related Macular Degeneration, Diabetic Retinopathy and Retinal Detachment

Age-Related Macular Degeneration (AMD) · Diabetic Retinopathy (DR) · Retinal Detachment

Abroad (travel likely)Recruiting

Roma, Italy

Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus

Diabetic Retinopathy (DR) · Diabete Mellitus · Fundus Photography

Abroad (travel likely)Recruiting

Incheon, South Korea

Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center

Diabetic Retinopathy (DR) · Macular Edema (ME)

Abroad (travel likely)Recruiting

San Francisco, United States

Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab

Diabetic Retinopathy (DR) · Diabetic Macular Edema (DME)

Abroad (travel likely)Recruiting

Osijek, Croatia